Recent Finacing
Recent Raise
RevealDx develops ML software that estimates cancer probability of lung nodules on chest CT scans to accelerate diagnosis, reduce false positives, and is undergoing FDA review with European users.
Focus Areas
Total Raised
Funding round
See the team members at Reveal-Dx.
